Cello Health

Cello Health is a global healthcare advisory and communications group that provides strategic marketing, medical communications, and market research services to the pharmaceutical and biotech industries. The company specializes in helping clients navigate complex commercial and clinical challenges throughout the product lifecycle, from early-stage development to post-launch. In 2020, Cello Health was acquired by Huntsworth, and in 2022, it was integrated into the newly formed Lumanity brand. Its core capabilities include market access, brand strategy, and scientific engagement, serving a majority of the world's top pharmaceutical companies. The firm is recognized for its deep technical expertise and its ability to translate complex science into compelling commercial narratives.